2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 22:32, 22 October 2023
, 22 October 2023no edit summary
No edit summary |
No edit summary |
||
| Line 165: | Line 165: | ||
* improvement in muscle insulin sensitivity is clinically relevant and is similar to the improvement observed after ~10% weight loss | * improvement in muscle insulin sensitivity is clinically relevant and is similar to the improvement observed after ~10% weight loss | ||
|- | |- | ||
|Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study | |Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study {{#pmid:34238308}} | ||
|[[RCT]], 6 weeks | |[[RCT]], 6 weeks | ||
* placebo (n=12) | * placebo (n=12) | ||